Apellis Pharmaceuticals Inc.
APLS
NGS
Sector: Healthcare
Industry: Biotechnology
62.33
USD
-1.00
(-1.58%)
Optionable: Yes Market Cap: 5,930 M 90-day average vol: 1,095,987
Previous close: 63.33 Open: 62.5 Bid: 66.99 Ask: 66.99
52 week range
27.50 67.74
Last updated: Tuesday 9th August 2022
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started todaySearch for a stock
Are you?
Chart
News
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
Yahoo Finance 3/2/2022
Apellis Pharmaceuticals, Inc. 2021 Q4 - Results - Earnings Call Presentation
Seeking Alpha 3/1/2022
Apellis (APLS) Q4 Loss Widens, Revenues Surpass Estimates
Yahoo Finance 3/1/2022
Apellis Pharmaceuticals, Inc. (APLS) CEO Cedric Francois on Q4 2021 Results - Earnings Call Transcript
Seeking Alpha 2/28/2022
Apellis Pharmaceuticals, Inc. (APLS) Reports Q4 Loss, Tops Revenue Estimates
Yahoo Finance 2/28/2022
Apellis Pharmaceuticals GAAP EPS of -$1.61 misses by $0.12, revenue of $60.29M beats by $51.51M
Seeking Alpha 2/28/2022
Apellis Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
Yahoo Finance 2/28/2022
Apellis Pharmaceuticals Q4 2021 Earnings Preview
Seeking Alpha 2/25/2022
5 Drug/Biotech Stocks Set to Outpace Q4 Earnings Estimates
Yahoo Finance 2/24/2022
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards?
Yahoo Finance 2/23/2022
Why Apellis (APLS) Might Surprise This Earnings Season
Yahoo Finance 2/23/2022
The Situation Has Improved At Apellis Pharmaceuticals In Recent Months
Seeking Alpha 2/22/2022
Apellis Pharmaceuticals to Host Conference Call on February 28, 2022 to Discuss Fourth Quarter and Full Year 2021 Financial Results
Yahoo Finance 2/22/2022
Avid (CDMO) to Report Q3 Earnings: What's in the Cards?
Yahoo Finance 2/21/2022
Apellis Pharmaceuticals, Inc. (APLS) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo Finance 2/17/2022
Investors bid Apellis Pharmaceuticals (NASDAQ:APLS) up US$777m despite increasing losses YoY, taking three-year CAGR to 51%
Yahoo Finance 2/10/2022
Did Hedge Funds Get Apellis Pharmaceuticals, Inc. (APLS) Right?
Yahoo Finance 2/7/2022
Top MarketXLS Rank stocks
Call: 1-877-778-8358
I am so happy you are here. My name is Ankur and I am the founder/CEO of MarketXLS. Over the past four years, I have helped more than 2500 customers to implement their own investment research strategies and monitoring systems in Excel.
Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS
Get started today
Stand with Ukraine
As the situation in Ukraine escalates, many of us in MarketXLS are left with emotions too overwhelming to name. If you’d like to show your support, but aren’t sure how to, we want to help make it easier for you to act.
For any amount donated, we’ll extend your MarketXLS subscription for double of the donated amount. Please send proof of your payment to support@marketxls.com to avail the extention
From all of us at MarketXLS, thank you!